[Experimental and clinical study of Vasosan P, a new form of pectin-enriched cholestyramine].
The bile acid sequestering agent Vasosan P is a new form of pectin-enriched cholestyramine (20%), saccharose (5%) and sorbic acid (0.18%). In comparison with cholestyramine Vasosan P has a more marked hypolipidemic effect in experiment. Vasosan P is remarkable for good organoleptic properties. It is effective in treating patients with type IIa hyperlipoproteinemia and practically has no side effects as cholestyramine.
Ryzhenkov
V E
VE
Chistiakova
A M
AM
Triufanov
V F
VF
Vasil'eva
L E
LE
Frolova
Iu V
IuV
Solov'eva
M A
MA
Remezova
O V
OV
Lozovskiĭ
V T
VT
Khanefel'd
M
M
Leonkhardt
V
V
D000818:Animals; D002784:Cholesterol / Q000097:blood; D002792:Cholestyramine Resin / Q000009:adverse effects / Q000627:therapeutic use*; D006168:Guinea Pigs; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000188:drug therapy*; D006938:Hyperlipoproteinemia Type II / Q000097:blood / Q000188:drug therapy*; D050356:Lipid Metabolism; D008055:Lipids / Q000097:blood; D008079:Lipoproteins, VLDL / Q000097:blood; D008099:Liver / Q000378:metabolism; D051381:Rats; D014280:Triglycerides / Q000097:blood
D008055:Lipids; D008079:Lipoproteins, VLDL; D014280:Triglycerides; D002792:Cholestyramine Resin; D002784:Cholesterol
Eksperimental'noe i klinicheskoe izuchenie vasozana P--novoĭ formy kholestiramina, obogashchennogo pektinom.